THERMAZENE
Live / Registered — Registered (as of 26 Mar 2024)
What this means for you
Registered since 26 Mar 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 26 Mar 2030: the §8 declaration of use).
Record
- Serial number
- 97030487
- Registration number
- 7340442
- Mark type
- Word mark
- Filed
- 16 Sept 2021
- Published for opposition
- 22 Mar 2022
- Registered
- 26 Mar 2024
- Next maintenance filing
- §8 declaration of use, due by 26 Mar 2030 (grace period to 26 Sept 2030)
- Attorney of record
- Howard Shipley
Goods and services
- Class 005 — Pharmaceuticals: MEDICAL OINTMENT FOR TOPICAL APPLICATION USED FOR THE PREVENTION AND TREATMENT OF WOUND SEPSIS
Owner
- Ascend Laboratories, LLC, Parsippany, NJ, US
- Ascend Laboratories, LLC, Parsippany, NJ, US
- Ascend Laboratories, LLC, Parsippany, NJ, US
Prosecution history
- 26 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 22 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Feb 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Feb 2024 — ASSIGNED TO LIE
- 26 Sept 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Jul 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Jul 2023 — NON-FINAL ACTION E-MAILED
- 03 Jul 2023 — SU - NON-FINAL ACTION - WRITTEN
- 09 Jun 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Nov 2022 — USE AMENDMENT FILED
- 05 Dec 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Nov 2022 — TEAS STATEMENT OF USE RECEIVED